AJP - Heart Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 286: H108-H112, 2004. First published August 28, 2003; doi:10.1152/ajpheart.00542.2003
0363-6135/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/1/H108    most recent
00542.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iversen, V. V.
Right arrow Articles by Reed, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iversen, V. V.
Right arrow Articles by Reed, R. K.

Continuous measurements of plasma protein extravasation with microdialysis after various inflammatory challenges in rat and mouse skin

V. V. Iversen, A. Brønstad, E.-A. B. Gjerde, and R. K. Reed

Department of Physiology, University of Bergen, N-5009 Bergen, Norway

Submitted 24 June 2003 ; accepted in final form 21 August 2003


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
This study describes the use of microdialysis technique for continuous measurement of plasma protein extravasation (PPE) in rat and mouse skin with drug application either intravenously or via the microdialysis fiber. Hollow plasmapheresis fibers (3-cm length, 0.4-mm diameter, cutoff 3,000 kDa) were placed subcutaneously on the back of anesthetized mice and rats. Intravenous injection of dextran (Macrodex, 60 mg/ml) increased PPE by 355% from baseline within 30 min in rats with ligated kidneys (n = 6; P < 0.05) but not in animals with intact kidneys. Phalloidin (500 µg/kg iv 40 min before dextran, n = 6; P < 0.05) did not change the response to dextran in either group. Animals receiving PGE1, compound 48/80 (mice), paclitaxel, docetaxel, and cremophor EL via the microdialysis fiber were also provided with a control fiber receiving vehicle. Both rats and mice had constant PPE in the control fiber, and there was no change in PPE in the NaCl-treated groups (rats, n = 4; mice, n = 6). Application via the fiber of PGE1 (20 µg/ml), compound 48/80 (mice; 4 mg/ml), and docetaxel (0.5 mg/ml) increased PPE compared with baseline within 60 min by 139% (n = 6; P < 0.05), 273% (n = 6; P < 0.05), and 325% (n = 5; P < 0.05), respectively. Phalloidin alone did not increase PPE (n = 5; P < 0.05). Pretreatment with phalloidin did not inhibit the increase after PGE1 or compound 48/80 but inhibited that after docetaxel (n = 6). Paclitaxel (0.6 mg/ml, n = 5) or vehicle (Cremophor) (n = 5) gave no increase in PPE. The results demonstrate that microdialysis can be used to continuously measure changes in PPE after inflammatory challenges in skin of rats and mice.

inflammation; permeability; microcirculation


THE PRIMARY AIM OF THIS STUDY was to evaluate and develop the microdialysis technique thoroughly with regard to its suitability for investigating plasma protein extravasation (PPE) in vivo in rat and mouse skin. Also, we wanted to test substances previously shown to either induce or reduce responses of interstitial fluid pressure (Pif) measured by the micropuncture technique and PPE measured as plasma clearance of radioactively marked albumin (3, 5, 9, 15).

Microdialysis with large-pore-size membranes has been used successfully to investigate neuropeptide-induced inflammation and PPE in human skin in vivo (16). First, this technique has the advantage of being relatively atraumatic. Second, it is possible to deliver large-sized molecular substances locally to the tissue via the fiber. Finally, the method allows continuous measurement of the response with simultaneous administration of the treatment. Acute inflammation in skin is accompanied by increased negativity of Pif, which increases capillary fluid filtration and thereby potentiates edema formation (12). Our group has over the years studied the effect of several inflammatory mediators on Pif with the micropuncture technique. Microdialysis complements these studies by measuring PPE. We previously measured (8) capillary-to-interstitium water transport after PGE1 by using microdialysis and 51Cr-EDTA as a tracer.

Compared with lymphatic and interstitial protein concentration for determination of capillary permeability, the microdialysis method has the advantage over lymphatic sampling that the sampling site is much closer to the capillary wall. This markedly reduces the time required to obtain a steady state. Also, the method has the advantage over isotope studies that the whole time course can be obtained for the event at the capillary-to-tissue exchange and not only a single point, which is the case when blood-to-tissue exchange with radioactive tracers is used.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Animals

Animals were obtained from M & B. They were fed a standard diet and tap water ad libitum and housed under conventional conditions. Female Wistar rats (200–250 g) were anesthetized with pentobarbital sodium (50 mg/kg body wt ip, with supplemental doses administered when required). Female C57 black mice were anesthetized at a volume of 0.1 ml/10 g body wt subcutaneously, with supplemental doses administered when required, of a 1:1:2 mixture of Hypnorm (fentanyl-fluanison), midazolam (5 mg/l), and distilled water. Cannulation of the left femoral vein was performed for intravenous injections of 125I-labeled human serum albumin (HSA), dextran, and phalloidin. The experiments in this study were performed with the approval of, and in accordance with the regulations laid down by, the Norwegian State Commission for Laboratory Animals.

Microdialysis

Microdialysis was performed as described by Schmelz et al. (16). Hollow plasmapheresis fibers (0.4-mm diameter, cutoff 3,000 kDa; PF2000, Gambro) were glued (Scotch superglue) to plastic tubing (PE-50) with an active membrane of 3 cm. Two microdialysis fibers were placed subcutaneously: longitudinally on both sides of the spine of mice and transversally on the back of rats with a distance of 4 cm between the fibers. The fibers were perfused with 0.9% NaCl by a microdialysis pump (CMA/100) at a constant flow rate of 5 µl/min. The dialysate was collected after passage through the skin at 10-min intervals from 6-cm-long outlet tubing inserted in plastic vials (Eppendorf). After a stabilization period of 30 min, a baseline period of 30–40 min commenced. After the baseline period, the effects of the substances were recorded for 70 min: either dextran or phalloidin (iv; both as bolus injection) or PGE1, docetaxel, paclitaxel, Cremophor EL, or compound 48/80 was given continuously via the fiber. In the experiments in which the substance was given via the fiber, a control fiber was perfused with saline during the whole experiment. Capillary-to-interstitium transport of protein by microdialysis after intravenous injection of 125I-HSA (Institute For Energy Technique, Kjeller, Norway) was determined in a gamma counting system (LKB Wallac, Turku, Finland) with automatic background and spillover correction. The stock solution of 125I-HSA contained <3% free iodide according to the manufacturer.

Radioactivity in the baseline period (30–40 min) was set as the basal extravasation of protein. Experimental values after injection of the active substance were calculated as a percentage of baseline. In vitro recovery for 125I-HSA was measured by perfusing single hollow fibers at 5 µl/min placed in a saline containing 125I-HSA and with an active microdialysis membrane of 3 cm as in the in vivo studies. The in vitro recovery of the fibers was found to be 45 ± 10% when placed in aqueous solution.

Experimental Protocol

After the surgical procedures and implantation of the microdialysis fibers were completed, the animal was left to stabilize for 30 min with the fibers being perfused with saline at a rate of 5 µl/min. The animals then received 0.2 ml of 125I-HSA (10 MBq) intravenously circulated for another 10 min. Sampling for the subsequent 30–40 min represented a baseline with collection of the dialysate in sampling vials every 10 min. After the baseline period, tubing was swapped from syringes containing saline to syringes containing the substance under study by a liquid switch (CMA/110) in the experiments in which the substance was delivered via the fiber. In the experiments in which the substance was given intravenously there was no swapping of syringes. Sampling of dialysate progressed for 70 min with collection of the dialysate every 10 min.

Experimental Groups

Dextran. Dextran (0.2 ml) was injected intravenously (Macrodex; 60 mg/ml) in six rats with ligated kidneys and four rats with nonligated kidneys.

Compound 48/80. Compound 48/80 (Sigma, St. Louis, MO) was used at 4 mg/ml and was given via the microdialysis fiber (n = 6).

Prostaglandin E1. PGE1 (Sigma) was used at 20 µg/ml and given via the microdialysis fiber (n = 6).

Paclitaxel. Paclitaxel (Taxol, paclitaxel in ethanol and its solvent Cremophor EL; Bristol-Myers Squibb) was supplied at 6 mg/ml and used at 0.6 mg/ml after dilution in sterile saline (0.9% NaCl) and was given via the microdialysis fiber (n = 5).

Docetaxel. Docetaxel (Taxotere, docetaxel 40 mg/ml, Aventis Pharma) was diluted to concentration of 0.5 mg/ml. The solution was used within 8 h after dilution and was given via the microdialysis fiber (n = 5).

Phalloidin. Phalloidin (Sigma) was dissolved in sterile saline (0.9% NaCl) to a final concentration of 1 mg/ml and was given at a dose of 500 µg/kg and administered 40 min before the second agent studied. One group of mice also received pretreatment with 50 µg/kg phalloidin before compound 48/80.

Statistical Methods

One-way ANOVA and subsequent Bonferroni post hoc tests were used. P < 0.05 was considered statistically significant. Values are means ± SE of percent increase compared with baseline.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Control Groups

Fibers perfused with saline over a period of 30–40 min (baseline) plus 70 min (experimental) showed no change in PPE over the entire period compared with baseline (set as 100%). Pretreatment with phalloidin (n = 5) or Cremophor EL (n = 5) did not increase PPE during the experiment (Figs. 1 and 2).



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1. Control series with Cremophor EL and NaCl did not induce any plasma protein extravasation (PPE) in rats.

 


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2. Paclitaxel did not increase PPE in rats compared with baseline.

 

Experimental Groups

Experiments in rats. Intravenous injection of 0.2 ml dextran (60 mg/ml) increased PPE significantly by 355% (±59.7% SE) in rats with ligated kidneys compared with baseline after 30 min (the period of maximal radioactivity in the sample) (n = 6; P < 0.05), whereas it did not alter PPE from baseline in rats with nonligated kidneys (n = 4) (Fig. 3). The increase observed after intravenous injection of dextran was not significantly reduced in animals pretreated with phalloidin (500 µg/kg iv) 40 min before dextran when the kidneys were ligated. (n = 6; P < 0.05). However, when the kidneys were intact the increase in PPE after dextran was significantly reduced (P < 0.05; Fig. 3).



View larger version (22K):
[in this window]
[in a new window]
 
Fig. 3. Intravenous injection of dextran increases PPE by ~350% in rats with ligated kidneys. Pretreatment with phalloidin did not influence the increase. There was no increase in PPE in animals without kidney ligature. *P < 0.05.

 

PGE1 (15 µg/ml) given via the fiber increased PPE significantly by 139% (±73% SE), and maximal radioactivity in the sample was seen after 40 min (n = 6; P < 0.05). Pretreatment with phalloidin before PGE1 did not significantly inhibit the increase in PPE by PGE1 (n = 6; P < 0.05; Fig. 4).



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4. Local administration of PGE1 in rats gave an increase of 140% of baseline. Phalloidin did not inhibit this increase. *P < 0.05.

 

Docetaxel (0.5 mg/ml) increased PPE significantly compared with baseline within 60 min by 325%(±75.4% SE; n = 5; P < 0.05). Pretreatment with phalloidin before docetaxel significantly inhibited the increase in PPE (n = 6; P < 0.05; Fig. 5). Paclitaxel did not change PPE significantly compared with control (n = 5).



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5. Local administration of docetaxel in rats increased PPE ~325%. Pretreatment with phalloidin totally abolished this increase. *P < 0.05.

 

Experiments in mice. Compound 48/80 significantly increased PPE by 273% (±55.6% SE), and maximum radioactivity in the sample was seen after 60 min (n = 6; P < 0.05; Fig. 6). Pretreatment with 500 µg/kg and 50 µg/kg phalloidin did not significantly inhibit the increase in PPE after compound 48/80.



View larger version (22K):
[in this window]
[in a new window]
 
Fig. 6. Local administration of compound 48/80 increased PPE ~270–500% in mice. Phalloidin did not inhibit this increase. *P < 0.05.

 


    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The substances used in the present study were demonstrated previously to induce or attenuate inflammatory reactions measured either as increased transcapillary albumin extravasation or as lowered Pif in the rat and mouse paw and trachea. This is the case for dextran, which induces an anaphylactic reaction in the rat (14), and the mast cell degranulating substance compound 48/80 (10). Also, infusion of PGE1 or carbaprostacyclin results in a fall in Pif in rat dermis, edema, and increased albumin extravasation (3). Furthermore, paclitaxel and docetaxel have been demonstrated to lower Pif and raise albumin extravasation. Finally, the actin-stabilizing agent phalloidin has been demonstrated to abolish or strongly attenuate the lowering of Pif and PPE and was therefore used to see whether these effects could also be verified with the use of the microdialysis technique.

The present study demonstrated that the microdialysis technique is suitable for measurement of PPE relatively atraumatically and continuously over a long period of time and with the immediate advantage of dramatically reducing the number of animals when measuring PPE at different time intervals, compared with timed sampling. The control groups (NaCl, phalloidin and Cremophor EL) had stable PPE at baseline level over the entire length of the experiments.

Free iodide should not be a source of error in the measurements because the albumin tracer contained <3% free iodide. On injection into the circulation, the majority of the iodide remains in the circulation because it is attached to the albumin. However, the free iodide is distributed in a space larger than extravascular space and consequently is <0.3% in plasma very shortly and thereafter remains a constant background throughout the experiment because of low renal clearance. Direct comparison of the control and experimental fibers will yield the effect, which can be directly ascribed to the experimental maneuver.

Two different routes of administration were used. Dextran and phalloidin were given intravenously, whereas the other substances were given via the fiber. Local administration via the fiber was shown previously to be the preferred route of administration rather than local administration in bolus injections around the fiber (8), which leads to several unfavorable effects. Administration by local injection increases Pif and lower colloid osmotic pressure, which both lower capillary filtration. The increased fluid volume will also increase the diffusion length between the capillaries and the microdialysis fiber. The use of the fiber to administer the substance in question prevents this.

Trauma from the inflammation and possibly a low-grade inflammatory response is likely to result from the implantation of the microdialysis fiber. However, this will be the same for the control fiber and for the experimental fiber. Thus subtraction of the response in the control fiber from that in the experimental fiber will yield the biological response elicited by the agent studied. However, because of a potential presence and effect of a low-grade inflammation in the control fiber, care should be taken at present to use the microdialysis method to determine the "normal" extravasation of plasma proteins in an undisturbed and unperturbed state.

The substances investigated here have an effect at both the capillary level and the interstitial level. In the present experimental situation, it is the combined effect of these two levels that was recorded and measured in the microdialysate. Thus the deduction of what occurs at the capillary level also requires the knowledge of their combined effect and separate data for either the capillary or the interstitial effects of the agent. The interstitial effect has been studied fairly extensively with a protocol implying circulatory arrest followed by immediate interstitial administration of the agent under study. Alternatively, the agent has been administered by the intravenous route and shortly thereafter (minutes) circulatory arrest has been induced to avoid the inflammatory effects in the microcirculation, i.e., vasodilation, increased capillary pressure, and increased permeability for water and protein. In our previous studies (4, 5), we were only able to obtain a single point in the time course of capillary extravasation of albumin, whereas the present method permits determination of the whole time course of the transcapillary albumin flux. In this measurement, the current method has the advantage over the traditional lymphatic sampling and determination of protein concentration that the interstitial steady state required for the lymphatic approach is much less of a problem, if any at all. Compared with the isotope method using plasma-to-tissue clearance and subsequent tissue sampling, the current method has the advantage of allowing determination of the time course of the flux rather than a single point. On the other hand, the use of the microdialysis method with 125I-HSA does not allow determination of the increase in the transcapillary fluid flux, which, through the use of biopsies, is approximated by the increase in total tissue water.

In previous studies on rats, phalloidin attenuated the response on PPE induced by dextran but not PGE1 (Ref. 5; A. Brønstad, unpublished observations). This is in agreement with the trend in the present data, although a significant difference was not obtained. Also, in the present experiments there is some (statistically insignificant) lowering of PPE induced by phalloidin before PGE1, in agreement with the observation that, although phalloidin abolished lowering of Pif induced by PGE1, there was little effect on transcapillary albumin flux (A. Brønstad, unpublished observations). Similarly, the effects of dextran and docetaxel were more distinct also on the PPE, attesting to an effect both on the capillary and interstitial level. Furthermore, the time course of PPE is different with the three substances and in rats, with a marked peak after dextran at four times baseline, a doubling with a plateau after PGE1, and a constant increase during the period of observation after docetaxel. Finally, it should be noted that the increase in PPE is completely abolished after pretreatment with phalloidin. Together, the diverse effects of phalloidin on the increase in PPE induced by dextran, docetaxel, and PGE1 strongly suggest that these three agents have different sites of actions with regard to their effect on connective tissue cells and capillary endothelial cells. In mice, after compound 48/80 there is seemingly the opposite effect in that phalloidin in a seemingly dose-independent manner raises PPE above that seen with compound 48/80 alone but does not reach statistical significance.

Acute inflammation is associated with increased transcapillary flux and formation of edema (2, 14). We previously demonstrated (13) that the lowering of Pif seen in acute inflammation contributes to edema formation. It is believed that this is regulated by {beta}-integrin-mediated interactions between the connective tissue cells and the extracellular matrix. Blockade of {beta}-integrin function causes lowering of Pif and edema (13), and it is believed that the connective tissue cells actively contribute to the regulation of Pif. {beta}-Integrins are heterodimeric transmembrane receptors, which attach the cells to the extracellular matrix. The cell cytoskeleton is important for integrin function. Modulation of cell cytoskeleton function can modulate Pif and therefore the formation of edema. (5). Actin filaments are a group of cytoskeletal proteins that are important for locomotor functions of the cell and for the function of the {beta}-integrins. Actin filaments (F-actin) are built up by polymerization of globular actin (G-actin) units. Depolymerization of actin filaments with cytochalasin D lowers Pif and causes edema (4). Phalloidin from the mushroom Amanita phalloides stabilizes the actin filament system by inducing the assembly of F-actin (6, 17). It was shown previously that phalloidin attenuates inflammation induced by several inflammatory mediators as well as in ischemia-reperfusion injury (1, 11). Brønstad et al. (5) demonstrated that phalloidin pretreatment attenuated lowering of Pif, albumin extravasation and edema formation induced by dextran anaphylaxis, which is mediated by mast cell degranulation. The present data are in agreement with these studies.

We found an increase in PPE of 355% of baseline within 30 min after dextran in rats. For unexplained reasons pretreatment with phalloidin was only effective in rats when the kidneys were not ligated. When the kidneys were ligated, we observed the same PPE as in those treated only with dextran. Compound 48/80 administered to mice gave an increase of 273% of baseline. Pretreatment with phalloidin did not abolish this increase.

Microtubules, another group of cytoskeletal proteins, are built up by polymerization of tubulin monomers. Both actin filaments and microtubules are dynamic structures and are continuously reconstructed. The half-life of a microtubule is ~10 min. Paclitaxel and docetaxel belong to the taxanes and are derived from different yew trees (Taxus spp.). These substances are known to bind to the microtubules and thereby prevent depolymerization. Subdermal injection of paclitaxel and docetaxel caused lowering of Pif and edema (A. Brønstad, unpublished observations). Danowski (7) proposed a "push and pull theory" in which microtubulifixation causes reduced contractility of fibroblasts by opposing the contractile force induced by the actin filaments. This model would seem to explain the seeming contradiction that fixation of the three cytoskeletal structures caused opposite effects. Paclitaxel did not increase PPE. Docetaxel, however, increased PPE by 325% within 60 min. The lowering of Pif after docetaxel has been prevented by pretreatment with phalloidin (A. Brønstad, unpublished observations), which is in good agreement with the present study, because pretreatment with phalloidin completely abolished the increase in PPE observed after docetaxel alone. As discussed above, the effects of all substances tested here act at both the capillary and interstitial levels and it is their combined response that arises as PPE.

Cremophor EL is the solvent for paclitaxel. It has been suggested to have proinflammatory properties and cause adverse affects observed when paclitaxel (Taxol; 6 mg/ml) is used in cancer patients. Cremophor EL was tested on the effect on Pif and albumin extravasation in a previous study (A. Brønstad, unpublished observations). A similar conclusion was reached in this study, i.e., there was no effect above that of physiological saline.

PGE1 resulted in doubling of PPE within 60 min, and this increase was not attenuated by pretreatment with phalloidin, demonstrating that phalloidin does not prevent PPE induced by PGE1. This is in good agreement with a similar study (5) using the plasma clearance method with 25-min transcapillary extravasation of 125I-HSA and where phalloidin also failed to reduce edema formation. The results from the present study demonstrate that measurement of PPE with microdialysis is in good agreement with what has been shown in previous studies measuring either Pif, with the micropuncture method, or PPE, with the isotope-marked albumin clearance method.

In conclusion, the present study has demonstrated that the microdialysis technique can be used to measure increases in transcapillary transport of 125I-HSA in rat and mouse skin using this approach. The method gives an impression of the extravasation of plasma proteins over time and uses a small number of animals.


    ACKNOWLEDGMENTS
 
Technical assistance by Gerd Signe Salvesen is greatly appreciated.

GRANTS

The present study received financial support from The Norwegian Heart Association and The Norwegian Research Council.


    FOOTNOTES
 

Address for reprint requests and other correspondence: V. V. Iversen, Dept. of Physiology, Jonas Lies vei 91, N-5009 Bergen, Norway (E-mail: vegard.iversen{at}fys.uib.no).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Asako H, Wolf RE, Granger DN, and Korthuis RJ. Phalloidin prevents leukocyte emigration induced by proinflammatory stimuli in rat mesentery. Am J Physiol Heart Circ Physiol 263: H1637–H1642, 1992.[Abstract/Free Full Text]
  2. Aukland K and Reed RK. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev 73: 1–78, 1993.[Abstract/Free Full Text]
  3. Berg A, Ekwall AK, Rubin K, Stjernschantz J, and Reed RK. Effect of PGE1, PGI2, and PGF2{alpha} analogs on collagen gel compaction in vitro and interstitial pressure in vivo. Am J Physiol Heart Circ Physiol 274: H663–H671, 1998.[Abstract/Free Full Text]
  4. Berg A, Rubin K, and Reed RK. Cytochalasin D induces edema formation and lowering of interstitial fluid pressure in rat dermis. Am J Physiol Heart Circ Physiol 281: H7–H13, 2001.[Abstract/Free Full Text]
  5. Brønstad A, Reith A, Berg A, and Reed RK. Effect of the cytoskeletal fixation agent phalloidin on transcapillary albumin transport and interstitial fluid pressure in anaphylaxis in the wistar rat. Microcirculation 9: 197–205, 2002.[CrossRef][ISI][Medline]
  6. Cooper JA. Effects of cytochalasin and phalloidin on actin. J Cell Biol 105: 1473–1478, 1987.[Free Full Text]
  7. Danowski BA. Fibroblast contractility and actin organization are stimulated by microtubule inhibitors. J Cell Sci 93: 255–266, 1989.[Abstract/Free Full Text]
  8. Iversen VV and Reed RK. PGE1 induced transcapillary transport of 51Cr-EDTA in rat skin measured by microdialysis. Acta Physiol Scand 176: 269–274, 2002.[CrossRef][ISI][Medline]
  9. Koller ME and Reed RK. Increased negativity of interstitial fluid pressure in rat trachea in dextran anaphylaxis. J Appl Physiol 72: 53–57, 1992.[Abstract/Free Full Text]
  10. Koller ME, Woie K, and Reed RK. Increased negativity of interstitial fluid pressure in rat trachea after mast cell degranulation. J Appl Physiol 74: 2135–2139, 1993.[Abstract/Free Full Text]
  11. Korthuis RJ, Carden DL, Kvietys PR, Shepro D, and Fuseler J. Phalloidin attenuates postischemic neutrophil infiltration and increased microvascular permeability. J Appl Physiol 71: 1261–1269, 1991.[Abstract/Free Full Text]
  12. Lund T, Wiig H, and Reed RK. Acute postburn edema: role of strongly negative interstitial fluid pressure. Am J Physiol Heart Circ Physiol 255: H1069–H1074, 1988.[Abstract/Free Full Text]
  13. Reed RK, Berg A, Gjerde EA, and Rubin K. Control of interstitial fluid pressure: role of {beta}1-integrins. Semin Nephrol 21: 222–230, 2001.[CrossRef][ISI][Medline]
  14. Reed RK and Rodt SA. Increased negativity of interstitial fluid pressure during the onset stage of inflammatory edema in rat skin. Am J Physiol Heart Circ Physiol 260: H1985–H1991, 1991.[Abstract/Free Full Text]
  15. Rubin K, Sjoquist M, Gustafsson AM, Isaksson B, Salvessen G, and Reed RK. Lowering of tumoral interstitial fluid pressure by prostaglandin E1 is paralleled by an increased uptake of 51Cr-EDTA. Int J Cancer 86: 636–643, 2000.[CrossRef][ISI][Medline]
  16. Schmelz M, Luz O, Averbeck B, and Bickel A. Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis. Neurosci Lett 230: 117–120, 1997.[CrossRef][ISI][Medline]
  17. Wieland T and Faulstich H. Amatoxins, phallotoxins, phallolysin, and antamanide: the biologically active components of poisonous Amanita mushrooms. CRC Crit Rev Biochem 5: 185–260, 1978.[ISI][Medline]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. A. Borge, V. V. Iversen, and R. K. Reed
Changes in plasma protein extravasation in rat skin during inflammatory challenges evaluated by microdialysis
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2108 - H2115.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Bronstad, A. Berg, and R. K. Reed
Effects of the taxanes paclitaxel and docetaxel on edema formation and interstitial fluid pressure
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H963 - H968.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/1/H108    most recent
00542.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iversen, V. V.
Right arrow Articles by Reed, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iversen, V. V.
Right arrow Articles by Reed, R. K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.